Cancer Genetics Inc (CGIX) Stock Price, Quote, News and Overview
NASDAQ:CGIX - Nasdaq -
CGIX Quote, Performance and Key Statistics
4.61
-0.11 (-2.33%)
The current stock price of CGIX is 4.61 null. In the past month the price decreased by -21.73%. In the past year, price increased by 45.89%.
About CGIX
Company Profile
Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also offers non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. Cancer Genetics, Inc. is headquartered in Rutherford, New Jersey.
Company Info
Cancer Genetics Inc
201 ROUTE 17 NORTH 2ND FLOOR
RUTHERFORD NJ 07070
CEO: John A. Roberts
Phone: 201-528-9200
Cancer Genetics Inc / CGIX FAQ
What is the stock price of Cancer Genetics Inc today?
The current stock price of CGIX is 4.61 null. The price decreased by -2.33% in the last trading session.
What is the ticker symbol for Cancer Genetics Inc stock?
The exchange symbol of Cancer Genetics Inc is CGIX and it is listed on the Nasdaq exchange.
On which exchange is CGIX stock listed?
CGIX stock is listed on the Nasdaq exchange.
What is Cancer Genetics Inc worth?
Cancer Genetics Inc (CGIX) has a market capitalization of 18.83M null. This makes CGIX a Nano Cap stock.
What are the support and resistance levels for Cancer Genetics Inc (CGIX) stock?
Cancer Genetics Inc (CGIX) has a resistance level at 6.49. Check the full technical report for a detailed analysis of CGIX support and resistance levels.
Should I buy Cancer Genetics Inc (CGIX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CGIX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CGIX, evaluating the profitability, health, valuation and growth aspects
- Cancer Genetics Inc (CGIX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Cancer Genetics Inc (CGIX) Sales and EPS estimates to see what analysts future expectations are.
- Cancer Genetics Inc (CGIX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Cancer Genetics Inc (CGIX) Insider and Institutional Ownership to learn about the owners and their transactions.
- Cancer Genetics Inc (CGIX) Stock Chart to make your own analysis
- Cancer Genetics Inc (CGIX) Latest news and press-releases to stay up to date.
Does Cancer Genetics Inc (CGIX) stock pay dividends?
CGIX does not pay a dividend.
What is the Price/Earnings (PE) ratio of Cancer Genetics Inc (CGIX)?
Cancer Genetics Inc (CGIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.25).
CGIX Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CGIX. When comparing the yearly performance of all stocks, CGIX is one of the better performing stocks in the market, outperforming 76.32% of all stocks.
CGIX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CGIX. CGIX has a bad profitability rating. Also its financial health evaluation is rather negative.
CGIX Financial Highlights
Over the last trailing twelve months CGIX reported a non-GAAP Earnings per Share(EPS) of -1.25. The EPS increased by 60.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -71.5% | ||
| ROA | -46.7% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |